ImpediMed Limited (IPDQF)
OTCMKTS
· Delayed Price · Currency is USD
0.0336
0.00 (0.00%)
Jun 10, 2025, 8:00 PM EDT
ImpediMed Revenue
ImpediMed had revenue of 6.01M AUD in the half year ending December 31, 2024, with 6.24% growth. This brings the company's revenue in the last twelve months to 11.54M, up 10.22% year-over-year. In the fiscal year ending June 30, 2024, ImpediMed had annual revenue of 10.32M, down -9.04%.
Revenue (ttm)
11.54M AUD
Revenue Growth
+10.22%
P/S Ratio
5.73
Revenue / Employee
139.07K AUD
Employees
83
Market Cap
40.95M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 10.32M | -1.03M | -9.04% |
Jun 30, 2023 | 11.34M | 778.00K | 7.36% |
Jun 30, 2022 | 10.57M | 2.16M | 25.65% |
Jun 30, 2021 | 8.41M | 2.67M | 46.47% |
Jun 30, 2020 | 5.74M | 1.59M | 38.14% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
ImpediMed News
- 9 months ago - Impedimed Ltd (ASX:IPD) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and ... - GuruFocus
- 9 months ago - Impedimed Ltd (ASX:IPD) Q4 2024 Earnings Call Transcript Highlights: Strong Core Business ... - GuruFocus
- 9 months ago - Full Year 2024 ImpediMed Ltd Earnings Call Transcript - GuruFocus
- 9 months ago - ImpediMed Ltd Ordinary Shareholders Meeting Transcript - GuruFocus
- 9 months ago - Half Year 2024 ImpediMed Ltd Earnings Call Transcript - GuruFocus